Company / Operating Income per Share
GeneDx Holdings Corp. Operating Income per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.47
FY2025
5-year range
-$3597975.81 / -$0.47
FY2021-FY2025
Trend
+47.8%
vs FY2024
Sector context
#109 of 149
Health Care
What the data says
At $-0.47, GeneDx Holdings Corp.'s operating income per share ranks #109 of 149 in the Health Care sector. Operating Income per Share has increased for 4 consecutive years, from $-3597975.81 in FY2021 to $-0.47 in FY2025.
Based on SEC 10-K filings.
-0.47 in FY2025.
Improved from $-15.34 to $-0.47 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#109 of 149 in Health CareTop 73% of 149This company -$0.47 Sector average $4.30
▼
-110.9% below sector average
Key checks
Key Insights
- GeneDx Holdings Corp.'s operating income per share has grown for 4 consecutive years.
- In FY2025, operating income per share increased 47.8% year-over-year.
- Ranks #109 out of 149 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.47 | +47.8% |
| FY2024 | -$0.89 | +94.2% |
| FY2023 | -$15.34 | +100.0% |
| FY2022 | -$130121.22 | +96.4% |
| FY2021 | -$3597975.81 | -7528.8% |
| FY2020 | -$47163.13 | +80.8% |
| FY2019 | -$245266.13 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026